Metraipolis › archive › dc_4f73fa1e9de4

Niacin Derivatives in MASLD: Metabolic and Therapeutic Insights — Europe PMC PMID:41901171

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41901171
DOI
10.3390/nu18060996
License (as archived)
solo-consultazione
Archived
2026-11-04T04:31:41.870Z
SHA-256 of the archived text
36269b336662357d92fc0e255a1069a597d023db10d88b6ef1387dbf853f0a1a
Stable URL of this page
https://metraipolis.com/documento/dc_4f73fa1e9de4

How to cite

Niacin Derivatives in MASLD: Metabolic and Therapeutic Insights — Europe PMC PMID:41901171 — Europe PMC (en), https://europepmc.org/article/MED/41901171 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4f73fa1e9de4 (Metraipolis archive dc_4f73fa1e9de4, sha256 36269b336662357d92fc0e255a1069a597d023db10d88b6ef1387dbf853f0a1a)
BibTeX
@misc{dc4f73fa1e9de4,
  title = {Niacin Derivatives in MASLD: Metabolic and Therapeutic Insights — Europe PMC PMID:41901171},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41901171},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4f73fa1e9de4; sha256 36269b336662357d92fc0e255a1069a597d023db10d88b6ef1387dbf853f0a1a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41901171. Agents can read the archived copy with the MCP tool read_document.